Zymeworks is a clinical-stage biotechnology company unlocking new possibilities in cancer and autoimmune disease treatment. Our mission is to make a meaningful difference in the lives of patients by advancing a growing pipeline of next-generation antibody therapeutics, including T cell engagers and ...See more
Headquarters:
Canada
Company Type:
MNC / Large Enterprise
Company size:
201-500 Employees
Year Founded:
2003 (23 years)
Address:
114 E 4TH AVENUE; SUITE 800; VANCOUVER, BC V5T1G4, CA
The company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
LOW
spending power